Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells

Docetaxel treatment is a standard chemotherapy strategy for castration-resistant prostate cancer (CRPC), and patients with CRPC eventually develop resistance to treatment. However, little is understood regarding the underlying mechanism of resistance. The present study aimed to identify the underlyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Leihong, Gu, Xiaopeng, Zeng, Tao, Xu, Fanghua, Dong, Zhifeng, Liu, Chao, Chao, Haichao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676406/
https://www.ncbi.nlm.nih.gov/pubmed/31452801
http://dx.doi.org/10.3892/ol.2019.10623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676406/
https://www.ncbi.nlm.nih.gov/pubmed/31452801
http://dx.doi.org/10.3892/ol.2019.10623

Ejemplares similares